Cargando…

Upregulation of IBSP Expression Predicts Poor Prognosis in Patients With Esophageal Squamous Cell Carcinoma

Esophageal squamous cell carcinoma (ESCC), which is characterized by invasiveness and poor prognosis, is the sixth most common leading cause of cancer-related death worldwide. Despite advances in multimodality therapy, ESCC mortality remains high, and an understanding of the molecular changes that l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Mingyue, Liu, Baoxing, Li, Dan, Wu, Yufeng, Wu, Xuan, Jiao, Shuyue, Xu, Cong, Yu, Sheng, Wang, Shuai, Yang, Jianwei, Li, Yanmei, Wang, Qiming, Luo, Suxia, Tang, Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6823256/ https://www.ncbi.nlm.nih.gov/pubmed/31709184 http://dx.doi.org/10.3389/fonc.2019.01117

Ejemplares similares

Reduction of AZGP1 predicts poor prognosis in esophageal squamous cell carcinoma patients in Northern China
por: Tang, Hong, et al.
Publicado: (2016)

Predictive significance of HMGCS2 for prognosis in resected Chinese esophageal squamous cell carcinoma patients
por: Tang, Hong, et al.
Publicado: (2017)

RNA-binding protein CPSF6 regulates IBSP to affect pyroptosis in gastric cancer
por: Wang, Xue-Jun, et al.
Publicado: (2023)

Evolution of Lung Cancer in the Context of Immunotherapy
por: Yu, Sheng, et al.
Publicado: (2020)

Bone morphogenetic protein-7 upregulates genes associated with osteoblast differentiation, including collagen I, Sp7 and IBSP in gingiva-derived stem cells
por: Lee, Hyunjin, et al.
Publicado: (2019)

Upregulation of miR-1269 Contributes to the Progression of Esophageal Squamous Cell Cancer Cells and Is Associated With Poor Prognosis
por: Bai, Xiuhui, et al.
Publicado: (2021)

Pan-cancer analysis shows that IBSP is a potential prognostic and immunotherapeutic biomarker for multiple cancer types including osteosarcoma
por: Pan, Boyu, et al.
Publicado: (2023)

Exosomal miR-19a and IBSP cooperate to induce osteolytic bone metastasis of estrogen receptor-positive breast cancer
por: Wu, Kerui, et al.
Publicado: (2021)

IBSP, a potential recurrence biomarker, promotes the progression of colorectal cancer via Fyn/β‐catenin signaling pathway
por: Chen, Yan, et al.
Publicado: (2021)

Upregulation of METTL3 Expression Predicts Poor Prognosis in Patients with Esophageal Squamous Cell Carcinoma
por: Xia, Tian-Liang, et al.
Publicado: (2020)

Upregulation of MAGEA4 correlates with poor prognosis in patients with early stage of esophageal squamous cell carcinoma
por: Tang, Wei-Wei, et al.
Publicado: (2016)

Upregulation of SIX4 indicates poor clinical outcome and promotes tumor growth and cell metastasis in esophageal squamous cell carcinoma
por: Li, Yanping, et al.
Publicado: (2021)

Upregulation of SQLE Contributes to Poor Survival in Head and Neck Squamous Cell Carcinoma
por: Li, Jing, et al.
Publicado: (2022)

Clinical values of Ku80 upregulation in superficial esophageal squamous cell carcinoma
por: Wang, Shuai, et al.
Publicado: (2018)

HLA complex P5 upregulation is correlated with poor prognosis and tumor progression in esophageal squamous cell carcinoma
por: Wang, Yaqin, et al.
Publicado: (2022)

Case report: sequential use of almonertinib based on the EGFR exon 20 insertion mutation achieves long-term control for advanced non-small cell lung cancer patients
por: Wang, Ruilin, et al.
Publicado: (2022)

Upregulated expression of MMP family genes is associated with poor survival in patients with esophageal squamous cell carcinoma via regulation of proliferation and epithelial-mesenchymal transition
por: Xu, Guifeng, et al.
Publicado: (2020)

miRNA-92a-3p regulates osteoblast differentiation in patients with concomitant limb fractures and TBI via IBSP/PI3K-AKT inhibition
por: Hu, Liangcong, et al.
Publicado: (2021)

LHX2 Enhances the Malignant Phenotype of Esophageal Squamous Cell Carcinoma by Upregulating the Expression of SERPINE2
por: Li, Xukun, et al.
Publicado: (2022)

Upregulation of Centromere Proteins as Potential Biomarkers for Esophageal Squamous Cell Carcinoma Diagnosis and Prognosis
por: Wang, Xiao, et al.
Publicado: (2022)

Upregulation of microRNA-98 increases radiosensitivity in esophageal squamous cell carcinoma
por: Jin, Ying-Ying, et al.
Publicado: (2016)

Yes-associated protein (YAP) predicts poor prognosis and regulates progression of esophageal squamous cell cancer through epithelial-mesenchymal transition
por: Qu, Yan, et al.
Publicado: (2019)

High Serum Elafin Prediction of Poor Prognosis of Locoregional Esophageal Squamous Cell Carcinoma
por: Wu, I-Chen, et al.
Publicado: (2021)

Overexpressed PKMYT1 promotes tumor progression and associates with poor survival in esophageal squamous cell carcinoma
por: Zhang, Qingyi, et al.
Publicado: (2019)

Prognostic and diagnostic potential of isocitrate dehydrogenase 1 in esophageal squamous cell carcinoma
por: Chen, Xuan, et al.
Publicado: (2016)

EP300 as an oncogene correlates with poor prognosis in esophageal squamous carcinoma
por: Bi, Yanghui, et al.
Publicado: (2019)

The prognostic significance of metabolic syndrome and weight loss in esophageal squamous cell carcinoma
por: Liu, Bowen, et al.
Publicado: (2018)

Upregulation of SOX4 antagonizes cellular senescence in esophageal squamous cell carcinoma
por: Han, Rongfei, et al.
Publicado: (2016)

The Role of Tumor Microenvironment in Invasion and Metastasis of Esophageal Squamous Cell Carcinoma
por: Zheng, Shuyue, et al.
Publicado: (2022)

Elevated preoperative platelet distribution width predicts poor prognosis in Esophageal Squamous Cell Carcinoma
por: Song, Qian, et al.
Publicado: (2019)

Hypertension predicts a poor prognosis in patients with esophageal squamous cell carcinoma
por: Liang, Jie, et al.
Publicado: (2018)

High DEPTOR expression correlates with poor prognosis in patients with esophageal squamous cell carcinoma
por: Liu, Nan-bo, et al.
Publicado: (2015)

RACKI induces chemotherapy resistance in esophageal carcinoma by upregulating the PI3K/AKT pathway and Bcl-2 expression
por: Liu, Bowen, et al.
Publicado: (2018)

High expression of cytokeratin CAM5.2 in esophageal squamous cell carcinoma is associated with poor prognosis
por: He, Shujin, et al.
Publicado: (2019)

Expression of SIRT1 and survivin correlates with poor prognosis in esophageal squamous cell carcinoma
por: Yan, Li, et al.
Publicado: (2020)

IDO1 Expression Increased After Neoadjuvant Therapy Predicts Poor Pathologic Response and Prognosis in Esophageal Squamous Cell Carcinoma
por: Jiao, Ruidi, et al.
Publicado: (2020)

REDD1 overexpression in oral squamous cell carcinoma may predict poor prognosis and correlates with high microvessel density
por: Feng, Yuanyong, et al.
Publicado: (2020)

Down‐regulation of POTEG predicts poor prognosis in esophageal squamous cell carcinoma patients
por: Wang, Ling, et al.
Publicado: (2018)

High Expression of GOLPH3 in Esophageal Squamous Cell Carcinoma Correlates with Poor Prognosis
por: Wang, Jian-Hua, et al.
Publicado: (2012)

DNAJB6 Promotes Ferroptosis in Esophageal Squamous Cell Carcinoma
por: Jiang, Bin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_kd4h6468ccfd6coaf2h91tprqb